Abbott Laboratories

Abbott Laboratories is a equity in the USA market. The price is 123.67 USD currently with a change of 3.24 USD (0.03%) from the previous close. The latest open price was 122.62 USD and the intraday volume is 19,571,878. The intraday high is 125.61 USD and the intraday low is 121.15 USD. The latest trade time is Friday, July 18, 17:19:00 PDT.

Abbott Laboratories is a global healthcare company headquartered in Abbott Park, Illinois, United States. Founded in 1888 by Dr. Wallace Calvin Abbott, the company has grown into a diversified enterprise.

It offers a wide range of products and services aimed at improving health and well-being worldwide.

Product Portfolio

Abbott's extensive product portfolio is organized into several key divisions:

• Nutrition: This division provides nutritional products for various age groups and health needs, including brands for infants and children like Similac, Isomil, and PediaSure. For adults, products such as Ensure, Glucerna, and ZonePerfect cater to general health, diabetes care, and weight management.
• Diagnostics: Offers a comprehensive range of diagnostic tools and tests including core lab instruments, molecular diagnostics, point-of-care devices, and rapid diagnostics. Notable products include the i-STAT system, Alinity platforms, and BinaxNOW tests.
• Medical Devices: Develops and manufactures a wide array of devices such as the FreeStyle Libre continuous glucose monitoring system for diabetes, MitraClip for heart interventions, and neuromodulation devices for pain and movement disorders.
• Established Pharmaceuticals: Provides branded generic medicines, primarily in emerging markets, to address a broad spectrum of health conditions.

Global Presence

Abbott operates in over 160 countries, maintaining 89 manufacturing facilities worldwide, with 35 located within the United States.

In response to global trade uncertainties, Abbott announced a $500 million investment in U.S. manufacturing and research, with new projects in Illinois and Texas expected to begin by year-end.

Recent Developments

In April 2025, Abbott reaffirmed its profit forecast of $5.05 to $5.25 per share despite global tariff uncertainties affecting pharmaceuticals and medical devices. The company reported first-quarter adjusted earnings of $1.09 per share, beating expectations by $0.02 due to strong demand for glucose monitors and other devices. However, total revenue of $10.36 billion slightly missed estimates due to weaker diagnostics performance.

Abbott demonstrates commitment to innovation and global health through its Pandemic Defense Coalition, formed in 2021 to detect potential pandemic-level viruses and develop diagnostic tests, emphasizing proactive health preparedness.

Locations

Abbott Laboratories has a significant presence in the United States with offices and facilities in the following locations:

• Atlanta, GA
• Memphis, TN
• San Antonio, TX
• Portland, ME
• Springfield, MA
• San Francisco, CA
• Kenosha, WI
• Chesapeake, VA
• Overland Park, KS
• Milwaukee, WI
• Columbus, OH
• New Orleans, LA

These locations reflect Abbott's extensive operations across the United States, supporting its mission of improving health and well-being globally.